Anti-CD226/DNAM-1 Antibody, clone LeoA1 (Azide Free)

32160702

NA.41

CD226/DNAM1 is a T cell expressed plasma membrane receptor protein that plays multiple roles in lymphocyte signaling, intercellular adhesion, lymphokine secretion and cytotoxic T-cell and NK cell mediated killing. CD226 activates natural killer (NK) cell-mediated cytotoxicity and is a key player in the immune synapse between killer T cells and targets. Also, because it recognizes CD155 and nectins CD226/DNAM1 is being examined as a potential anti-cancer agent because soluble CD226 directly inhibits tumor growth by binding CD155 expressed on tumor cells and down regulating proliferation. CD226/DNAM-1 is expressed on Th1, but not Th2 or Th0 cells, it is also expressed on NK cells, CD8+ T-cells, but not developing T cells. CD226/DNAM-1 is also expressed on monocytes and platelets.

MABT398 does not work by western blotting under reducing conditions (for this application please see MABT341).

Whole cells corresponding to human CD226/DNAM-1.

Research Category
Cell Structure
Immunocytochemistry Analysis: A 1:50 dilution from a representative lot detected CD226/DNAM-1 in CD226 transfected CHO cells and non-transfected CHO cells.
Flow Cytometry Analysis: 1.0 µg of this antibody from a representative lot detected CD226/DNAM-1 in 1X10E6 CD226 transfected CHO cells.
Activity Assay Analysis: A representative lot detected CD226/DNAM-1 which induces platelet aggregation (Scott, J.L., et al. (1989). Journal of Biol. Chem. 264(23):13475-13482).
Competative Binding Assay Analysis: A representative lot detected CD226/DNAM-1 in the binding of this antibody to resting and pharmacologically activated PHA-induced blasts and Jurkat cells (Sherrington, P.D., et al. (1997). Journal of Biol. Chem. 272:21735-21744).
Inhibition Assay Analysis: A representative lot detected CD226/DNAM-1 which inhibited the induction of both CTL andAK cells from their precursors (Burns, G.F., et al. (1985). J. Exp. Med. 161:1063-1078).
Immunoprecipitation Analysis: A representative lot detected CD226/DNAM-1 in MLA-I44 cells (Burns, G.F., et al. (1985). J. Exp. Med. 161:1063-1078).
Immunoprecipitation Analysis: A representative lot detected CD226/DNAM-1 in Jurkat PTA-1 transfectants stimulated with TPA (Ralston, K.J., et al. (2004). Journal of Biol. Chem. 279:33816-33828).

This Anti-CD226/DNAM-1 Antibody, clone LeoA1 (Azide Free) is validated for use in Western Blotting and Immunocytochemistry and Flow Cytometry and Immunoprecipitation and Inhibition and Activity Assay for the detection of CD226/DNAM-1.
Research Sub Category
Adhesion (CAMs)

Evaluated by Western Blotting in CD226 transfected CHO cell lysate.

Western Blotting Analysis: 0.5 µg/mL of this antibody detected CD226/DNAM-1 in 10 µg of CD226 transfected CHO cell lysate.

Format: Purified
Purified mouse monoclonal IgG1κ in buffer containing PBS without preservatives.
Protein G Purified

Concentration: Please refer to lot specific datasheet.

100

mouse

purified antibody

primary antibodies

LeoA1, monoclonal

human

activity assay: suitable
flow cytometry: suitable
immunocytochemistry: suitable
immunoprecipitation (IP): suitable
inhibition assay: suitable
western blot: suitable

IgG1κ

NP_006557

Q15762

dry ice

human ... CD226(10666)

~39 kDa observed

Stable for 1 year at -20°C from date of receipt.
Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

12 - Non Combustible Liquids

WGK 2